[go: up one dir, main page]

TR200400234T4 - ''Stabil, nazal, oral veya sublingual uygulanabilen, desmopressin ihtiva eden farmasötik preparasyon'' - Google Patents

''Stabil, nazal, oral veya sublingual uygulanabilen, desmopressin ihtiva eden farmasötik preparasyon''

Info

Publication number
TR200400234T4
TR200400234T4 TR2004/00234T TR200400234T TR200400234T4 TR 200400234 T4 TR200400234 T4 TR 200400234T4 TR 2004/00234 T TR2004/00234 T TR 2004/00234T TR 200400234 T TR200400234 T TR 200400234T TR 200400234 T4 TR200400234 T4 TR 200400234T4
Authority
TR
Turkey
Prior art keywords
sublingual
nasal
oral
pharmaceutical preparation
desmopressin
Prior art date
Application number
TR2004/00234T
Other languages
English (en)
Inventor
Scheidl Helmut
Hantich Gerhard
Hesse Emst
Zapf Thomas
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3669975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200400234(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Publication of TR200400234T4 publication Critical patent/TR200400234T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus, aktif madde olarak sivi, özellikle de sulu bir desmoporessin çözeltisi seklinde hastalara, stabil, nazal, oral veya sublingual uygulanabilen farmasötik bir preparasyon ile ilgili olup, buradaki sivi çözelti, pH-degerini 4 ila 6, tercihen 5 mesahasinda tutan bir osmotikum ve bir tampon arz etmektedir.
TR2004/00234T 2000-02-16 2001-01-10 ''Stabil, nazal, oral veya sublingual uygulanabilen, desmopressin ihtiva eden farmasötik preparasyon'' TR200400234T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0023300A AT409081B (de) 2000-02-16 2000-02-16 Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

Publications (1)

Publication Number Publication Date
TR200400234T4 true TR200400234T4 (tr) 2004-03-22

Family

ID=3669975

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/00234T TR200400234T4 (tr) 2000-02-16 2001-01-10 ''Stabil, nazal, oral veya sublingual uygulanabilen, desmopressin ihtiva eden farmasötik preparasyon''

Country Status (20)

Country Link
US (1) US20030119728A1 (tr)
EP (1) EP1255557B1 (tr)
JP (1) JP2003529562A (tr)
AT (2) AT409081B (tr)
AU (1) AU771251B2 (tr)
CA (1) CA2399822A1 (tr)
CZ (1) CZ20022686A3 (tr)
DE (1) DE50100958D1 (tr)
DK (1) DK1255557T3 (tr)
ES (1) ES2210121T3 (tr)
HU (1) HU229961B1 (tr)
NO (1) NO20023875L (tr)
NZ (1) NZ520396A (tr)
PL (1) PL357132A1 (tr)
PT (1) PT1255557E (tr)
SI (1) SI21026B (tr)
SK (1) SK285374B6 (tr)
TR (1) TR200400234T4 (tr)
WO (1) WO2001060394A1 (tr)
ZA (1) ZA200205868B (tr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
AT413078B (de) * 2002-10-10 2005-11-15 Gebro Pharma Gmbh Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DK1500390T3 (da) 2003-07-25 2005-09-19 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
JP5079257B2 (ja) * 2005-05-16 2012-11-21 株式会社三和化学研究所 Ｂｕｒｋｈｏｌｄｅｒｉａｃｅｐａｃｉａに対する保存剤
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PT2712622T (pt) 2008-05-21 2016-10-13 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono tranquilo
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
UA115373C2 (uk) 2013-06-28 2017-10-25 Амген Інк. Стабільний рідкий склад amg 416 (велкалсетиду)
JP6341777B2 (ja) * 2014-06-30 2018-06-13 リプリーズ バイオファーマシューティクス，エルエルシー 低用量デスモプレシンを含有する医薬組成物
WO2016081772A1 (en) * 2014-11-20 2016-05-26 Allergan, Inc. Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist
GB201721846D0 (en) * 2017-12-22 2018-02-07 Arecor Ltd Novel composition
JP7579811B2 (ja) 2019-05-22 2024-11-08 バイオヴァイ インコーポレイテッド テルリプレシンの製剤
WO2024211393A2 (en) 2023-04-04 2024-10-10 Tulex Pharmaceuticals Inc. Desmopressin oral compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126014A (ja) * 1984-11-22 1986-06-13 Teijin Ltd 経鼻投与用水性液剤
JP2505430B2 (ja) * 1986-11-04 1996-06-12 帝人株式会社 塩基性アミノ酸を含有する経鼻投与用粉末状組成物
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
AU653026B2 (en) * 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
JPH0640948A (ja) * 1992-07-20 1994-02-15 Kyowa Hakko Kogyo Co Ltd イオントフォレシス用組成物
JP3628713B2 (ja) * 1993-06-07 2005-03-16 帝國製薬株式会社 生理学的に活性なペプチドを含有する膣投与製剤
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
ATE318138T1 (de) * 1998-06-30 2006-03-15 Takeda Pharmaceutical Pharmazeutisches mittel zur behandlung von diabetes
EP1185710A2 (en) * 1999-04-16 2002-03-13 Zymetx, Inc. Viral detection method using viral encoded enzymes and chemiluminescent substrates
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide

Also Published As

Publication number Publication date
NO20023875D0 (no) 2002-08-15
DK1255557T3 (da) 2004-03-22
AU771251B2 (en) 2004-03-18
NZ520396A (en) 2004-05-28
PL357132A1 (en) 2004-07-12
PT1255557E (pt) 2004-04-30
ATE253928T1 (de) 2003-11-15
HUP0204550A2 (en) 2003-05-28
SK10492002A3 (sk) 2003-02-04
CZ20022686A3 (cs) 2003-01-15
ES2210121T3 (es) 2004-07-01
HU229961B1 (hu) 2015-03-30
ATA2332000A (de) 2001-10-15
SK285374B6 (sk) 2006-12-07
NO20023875L (no) 2002-10-11
SI21026B (sl) 2004-02-29
HUP0204550A3 (en) 2004-12-28
ZA200205868B (en) 2004-02-10
AT409081B (de) 2002-05-27
EP1255557A1 (de) 2002-11-13
US20030119728A1 (en) 2003-06-26
SI21026A (sl) 2003-04-30
DE50100958D1 (de) 2003-12-18
WO2001060394A1 (de) 2001-08-23
JP2003529562A (ja) 2003-10-07
CA2399822A1 (en) 2001-08-23
AU2652001A (en) 2001-08-27
EP1255557B1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
TR200400234T4 (tr) ''Stabil, nazal, oral veya sublingual uygulanabilen, desmopressin ihtiva eden farmasötik preparasyon''
BR0015188A (pt) Composições farmacêuticas
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
JO3404B1 (ar) تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
TR200002615T2 (tr) Aspartil proteaz inhibitörleri önilaçları olarak sülfonamit türevleri.
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
BR0207715A (pt) Compostos, composições farmacêuticas, e uso de um ou mais compostos
BR0214757A (pt) Formulações farmacêuticas de derivados de platina
PL346764A1 (en) New oral formulation for 5-ht4
BR0012291A (pt) Fenoxifluorpirimidinas
BR9914644A (pt) Composições tamponadas para diálise
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
DE69521122D1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure-additions-salze
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
TR200103121T2 (tr) Prukaloprit oral çözelti.
UY27373A1 (es) Formulaciones de interferón beta-humano
BR9810556A (pt) Beta-alcoxiacrilatos contra a malária
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
DK1019037T3 (da) Lægemiddel indeholdende delta-aminolevulinsyre
PT1150660E (pt) Formulacao farmaceutica efervescente contendo metamizole
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény